AMT receives grant from Dutch parents organization for Duchenne Muscular Dystrophy gene therapy 07 Mar 2011 News
Prosensa agrees £412M deal with GSK for commercialisation of muscular dystrophy treatment 14 Oct 2009 News
Personalised medicine: patient groups call on regulators to set approval route A new campaign seeks to persuade regulators to set new rules for approving personalised treatments that are currently in clinical development. 07 Oct 2009 News